What is Sigenics?
Sigenics operates as a specialized provider of custom integrated circuits, offering comprehensive turnkey ASIC services that cater to the rigorous demands of the medical, aerospace, and industrial sectors. With over two decades of technical expertise, the firm excels in designing, testing, and delivering mixed-signal applications that prioritize high reliability. Beyond standard design services, Sigenics addresses critical supply chain challenges through reverse engineering for obsolete components, ensuring that legacy systems maintain their form, fit, and function. This unique market position allows the company to serve as a vital partner for organizations requiring bespoke silicon solutions where standard off-the-shelf components fail to meet stringent performance or compliance standards.
The company's operational model is built on deep collaboration, integrating client requirements directly into the design and production lifecycle. This methodology not only mitigates technical risk but also ensures that the final hardware meets the exact specifications required for mission-critical environments. By bridging the gap between complex analog design and industrial-grade manufacturing, Sigenics remains a cornerstone for innovation in sectors where failure is not an option.
How much funding has Sigenics raised?
Sigenics has raised a total of $1.4M across 3 funding rounds:
Grant
$1M
Debt
$150K
Debt
$225K
Grant (2017): $1M with participation from National Institutes of Health (NIH)
Debt (2020): $150K led by PPP
Debt (2021): $225K supported by PPP
Key Investors in Sigenics
National Institutes of Health (NIH)
The National Institutes of Health is the primary agency of the United States government responsible for biomedical and health-related research, providing critical grants to support medical technology innovation.
PPP
Public-Private Partnership
What's next for Sigenics?
With the recent influx of capital, Sigenics is well-positioned to scale its ASIC design capabilities and further penetrate the high-growth aerospace and medical device markets. The strategic deployment of these funds will likely focus on enhancing internal testing infrastructure and expanding the engineering team to support increasingly complex mixed-signal projects. As the industry faces ongoing supply chain volatility, Sigenics' ability to provide reverse engineering and obsolescence management will likely become a primary driver of revenue growth. Future strategic initiatives will likely involve deepening partnerships with government and private sector entities to standardize high-reliability circuit production, ensuring the company remains at the forefront of custom semiconductor innovation.
See full Sigenics company page
